Showing results (11-20 of 428) with videos related to
Sort By:
Pageof 43
Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MSFelix Luessi, Sinah Engel, Annette Spreer, et al.Brain : a Journal of Neurology|June 28, 2021
The potential of serum neurofilament as biomarker for multiple sclerosisStefan Bittner, Jiwon Oh, Eva Kubala Havrdová, et al.Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.Therapeutic Advances in Neurological Disorders|April 28, 2025
Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorderAmelie Kirschbaum, Felix Luessi, Arda Civelek, et al.Journal of Central Nervous System Disease|January 7, 2022
A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk FactorsSinah Engel, Lara S Molina Galindo, Stefan Bittner, et al.Ebiomedicine|December 19, 2022
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisMuriel Schraad, Timo Uphaus, Stefan Runkel, et al.Frontiers in Oncology|December 11, 2023
Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanomaKatrin Pape, Maria Protopapa, Muriel Schraad, et al.Therapeutic Advances in Neurological Disorders|January 11, 2020
PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disordersSinah Engel, Felix Luessi, Aneka Mueller, et al.Scientific Reports|November 25, 2020
The frequency of follicular T helper cells differs in acute and chronic neuroinflammationAdalie Baniahmad, Katharina Birkner, Johanna Görg, et al.Pageof 43